Cooperative group portfolio in locally advanced non-small-cell lung cancer: Are we making progress?

Clinical Lung Cancer

Volumn 9, Issue 2, 2008, Pages 85-91

  Langer, Corey J ^a   Wakelee, Heather ^b   Schiller, Joan ^c   Choy, Hak ^c   Shepherd, Frances ^d   Vokes, Everett E ^e   Adjei, Alex A ^f   Baas, Paul ^g   Saijo, Nagahiro ^h   Gandara, David R ⁱ  

^a FOX CHASE CANCER CENTER   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g NETHERLANDS CANCER INSTITUTE   (Netherlands)

^h NATIONAL CANCER CENTER HOSPITAL   (Japan)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cetuximab; Chemoradiation therapy; Etoposide; Radiation therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BORTEZOMIB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYTOTOXIC AGENT; DOCETAXEL; ERLOTINIB; ETOPOSIDE; GEFITINIB; GEMCITABINE; IRINOTECAN; MITOMYCIN; NAVELBINE; PACLITAXEL; PEMETREXED; PLACEBO; PROTEIN TYROSINE KINASE INHIBITOR; THALIDOMIDE; VINBLASTINE;

ADVANCED CANCER; AREA UNDER THE CURVE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG SAFETY; HUMAN; LEUKEMIA; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

EID: 43349085498     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2008.n.013     Document Type: Review

References (44)

1. Ries LA, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2004 , National Cancer Institute. [Web site]. Available at: http://seer.cancer.gov/csr/1975_2004/ . Based on November 2006 SEER data submission, posted to the SEER web site, 2007. Accessed: March 1, 2008.
2. RO Dillman SL Seagren J Herndon A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-smallcell lung cancer N Engl J Med 323 1990 940 945
3. RO Dillman J Herndon SL Seagren Improved survival in stage III nonsmall cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
4. WT Sause C Scott S Taylor Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer J Natl Cancer Inst 87 1995 198 205
5. WT Sause P Kolesar SG Taylor Five-year results: phase III trial of regionally advanced unresectable non-small cell lung cancer: final results of RTOG 8808, ECOG 4588, and SWOG 8992 Proc Am Soc Clin Oncol 17 1998 A 1743
6. T LeChevalier R Arrigada MJ Lacombe-Terrier Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma J Natl Clin Cancer Inst 84 1992 58
7. T LeChevalier A Auperin S Burdett Sequential radiochemotherapy versus radiotherapy alone and concomitant radiochemotherapy versus radiotherapy alone in locally advanced non-small cell lung cancer (NSCLC): two meta-analyses using individual patient data from randomized clinical trials J Thorac Oncol 2 suppl 4 2007 s309 (Abstract 1-04).
8. C Schaake-Koning W van den Bogaert O Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer N Engl J Med 326 1992 524 530
9. B Jeremic Y Shibamoto L Acimovic Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small cell lung cancer J Clin Oncol 13 1995 452 458
10. B Jeremic Y Shibamoto L Acimovic Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III nonsmall cell lung cancer J Clin Oncol 14 1996 1065 1070
11. K Furuse M Fukuoka M Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692
12. W Curran CB Scott CJ Langer Longterm benefit is observed in a phase II comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC Proc Am Soc Clin Oncol 22 2003 621 (Abstract 2499).
13. P Fournel G Robinet P Thomas Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study J Clin Oncol 23 2005 5910 5917
14. A Auperin E Rolland W Curran Concomitant radiochemotherapy RT-CT versus sequential RT-CT in locally advanced non-small cell lung cancer (NSLCLC): A meta-analysis using individual patient data from randomized clinical trials J Thorac Oncol 2 suppl 4 2007 S310 (Abstract A1-05).
15. DR Gandara K Chansky KS Albain Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504 J Clin Oncol 21 2003 2004
16. N Hanna M Neubauer R Ansari Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023 J Clin Oncol 25 18 suppl 2007 387s (Abstract 7512).
17. K Kelly LE Gaspar K Chansky Low incidence of pneumonitis on SWOG 0023: A preliminary analysis of an ongoing phase III trial of concurrent chemoradiotherapy followed by consolidation docetaxel and Iressa/placebo maintenance in patients with inoperable stage III non-small cell lung cancer J Clin Oncol 23 16 suppl 2005 634s (Abstract 7058).
18. K Kelly K Chansky LE Gaspar Updated analysis of SWOG 0023: A randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III non-small cell lung cancer J Clin Oncol 25 2007 388s (Abstract 7513).
19. EE Vokes JE Herndon MJ Kelley Cancer and Leukemia Group B Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B J Clin Oncol 25 2007 1698 1704
20. TY Seiwert PP Connell AM Mauer A phase I study of pemetrexed, Carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer Clin Cancer Res 13 2007 515 522
21. Erbitux® Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study. Press release September 11, 2007 ImClone Systems New York, NY
22. JA Bonner PM Harari J Giralt Radiotherapy plus cetuximab for squamouscell carcinoma of the head and neck N Engl J Med 354 2006 567 578
23. AW Blackstock C Ho J Butler Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B nonsmall cell lung cancer J Thorac Oncol 1 2006 434 440
24. MA Socinski JG Rosenman J Halle Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B non-small cell lung carcinoma: A modified phase I/II trial Cancer 92 2001 1213 1223
25. AW Blackstock MA Socinski J Bogart Induction plus concurrent chemotherapy with high dose (74Gy) 3-dimensional thoracic radiotherapy in stage III non-small cell lung cancer (NSCLC): Preliminary report of the Cancer and Leukemia Group B (CALGB) 30105 J Clin Oncol 24 18 suppl 2006 374s (Abstract 7042).
26. N Ready P Janne J Herndon Chemoradiotherapy (CRT) and gefitinib in stage III non-small celll lung cancer (NSCLC): A CALGB stratified phase II trial J Clin Oncol 24 2006 375s (Abstract 7046)
27. CP Belani W Wang DH Johnson Eastern Cooperative Oncology Group. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer J Clin Oncol 23 2005 3760 3767
28. K Kontani O Taguchi T Narita Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes Br J Cancer 84 2001 1258 1264
29. P Mukherjee LB Pathangey JB Bradley MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model Vaccine 25 2007 1607 1618
30. C Butts N Murray A Maksymiuk Randomized phase IIB trial of BLP25 Liposome Vaccine in stage IIIB and IV Non-Small-Cell Lung Cancer J Clin Oncol 23 2005 6674 6681
31. T Osada G Chong R Tansik The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients Cancer Immunol Immunother 2008 Epub ahead of print.
32. JP Van Meerbeeck GW Kramer C Legrand EORTC-Lung Cancer Group. Does downstaging in patients (pts) with IIIA-N2 non-small cell lung cancer (NSCLC) and a response to induction chemotherapy (ICT) influence outcome with surgery (S) or radiotherapy (RT)? An exploratory analysis of EORTC 08941 J Clin Oncol 24 18 suppl 2006 375s (Abstract 7047).
33. J Douillard R Rosell M Delena ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association Proc Am Soc Clin Oncol 23 2005 624s (Abstract 7013).
34. K Yoshida H Uejima M Satouchi Randomized phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carbplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small-cell lung cancer (NSCLC): WJTOG0105 J Thorac Oncol 2 suppl 4 2007 (Abstract C30-3).
35. S Schild W McGinnis D Graham Results of a Phase I/II trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small cell lung cancer Int J Radiat Oncol Biol Phs 63 suppl 1 2005 S44
36. JD Bradley M Graham S Swann Phase I results of RTOG L-0017: A phase I/II dose intensification study using 3D-CRT and concurrent chemotherapy for patients with inoperable NSCLC J Clin Oncol 23 16 suppl 2005 636s (Abstract 7063).
37. MP Mac Manus RJ Hicks JP Matthews Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J Clin Oncol 21 2003 1285 1292
38. MP Mac Manus RJ Hicks JP Matthews Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure Lung Cancer 49 2005 95 108
39. KS Albain JJ Crowley AT Turrisi 3rd Concurrent cisplatin, etoposide and chest radiotherapy in pathologic stage IIIB non-small cell lung cancer: A Southwest Oncology Group phase II study, SWOG 9019 J Clin Oncol 20 2002 3454 3460
40. VW Rusch DJ Giroux MJ Kraut Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) J Clin Oncol 25 2007 313 318
41. G Blumenshein J Moughan W Curran Phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (pts) with stage III A/B non-small cell lung cancer (NSCLC): An interim report of the RTOG 0324 trial J Clin Oncol 25 18 suppl 2007 392s (Abstract 7531).
42. P Vishnu S Srinivasan R Isaak Radiation pneumonitis in lung cancer patients treated with chemotherapy and thoracic radiation: retrospective analysis of patients treated at comprehensive cancer center J Thorac Oncol 2 suppl 4 2007 (Abstract P2-220).
43. LE Gaspar J McCoy K Kelly Analysis of V20 and radiation pneumonitis on SWOG 0023: a phase II trial of concurrent chemoradiation and docetaaxel consolidation in stage III non-small cell lung cancer Int J Radiat Oncol Biol Phys 66 suppl 1 2006 S61 S62
44. B Movsas J Moughan C Langer Randomized Trial of Amifostine in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy and Hyperfractionated Radiation (HRT): Long-Term Survival Results of Radiation Therapy Oncology Group (RTOG) 9801 J Clin Oncol 25 18 suppl 2007 391s (Abstract 7529).